GlycoMimetics Inc reports results for the quarter ended in December - Earnings Summary

Crescent Biopharma

03/03/2022 14:33

* GlycoMimetics Inc  GLYC.OQ  reported a quarterly adjusted
loss
of 33 cents​​ per share for the quarter ended in December. The
mean expectation of four analysts for the quarter was for a loss
of 34 cents per share.
    * Revenue fell 89% to $18.00 thousand from a year ago; 
analysts
expected zero. 
    * GlycoMimetics Inc's reported EPS for the quarter was a
loss
of 33 cents​.
    * The mean earnings estimate of analysts had risen by
about 1.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * GlycoMimetics Inc shares had fallen by 5.6% this quarter.
    * The company reported a quarterly loss of $17.42 million.
    * Wall Street's median 12-month price target for
GlycoMimetics Inc
is $9.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated March 3 at 02:33 p.m.  ​All
figures in US dollars unless otherwise stated